Risk factors and outcome of epilepsy in adults with cerebral palsy or intellectual disability.


Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
10 2023
Historique:
received: 07 07 2023
revised: 02 09 2023
accepted: 14 09 2023
medline: 23 10 2023
pubmed: 29 9 2023
entrez: 28 9 2023
Statut: ppublish

Résumé

Epilepsy is found in 10-60% of individuals with cerebral palsy (CP) and 5.5-35% with intellectual disability (ID). However, little is known about the long-term evolution of epilepsy among adults. The aim of the study is to describe the factors associated with epilepsy and its outcome in a population of adults with CP or ID. This retrospective study reviewed the medical records of 306 individuals with CP/ID. All individuals underwent neurological, psychiatric, and neuropsychological follow-ups. In the cohort, 72.5% of the individuals had a CP diagnosis, with a mean age of 36.4 years (IQR 24.0-46.0). Epilepsy was present in 55.6% of the individuals and was associated with CP (p < 0.01), spastic subtype (p < 0.01), a higher degree of ID (p < 0.01), hemorrhagic and congenital malformation etiologies (p 0.011), abnormal neuroimaging (p < 0.01), and worse scores on motor and communication scales (p < 0.01). Drug-resistant epilepsy (DRE) (22.4%) was associated with higher scores on motor scales (p < 0.01). Additionally, 42.3% of the individuals who attempted antiseizure medication (ASM) withdrawal experienced recurrence, which was associated with epileptic activity on the electroencephalogram (EEG) (p 0.004). Epilepsy is a common comorbidity in adults with CP or ID and is associated with greater brain damage and a more severe phenotype. Seizure recurrence after ASM withdrawal occurred in half of the individuals and was associated with epileptic activity on the EEG.

Identifiants

pubmed: 37769423
pii: S1525-5050(23)00369-4
doi: 10.1016/j.yebeh.2023.109450
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109450

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have seemed to influence the work reported in this paper.

Auteurs

Isabel Fernández Pérez (IF)

Neurology Department, Fundació ASPACE Catalunya, Barcelona, Spain; Neurology Department, Hospital del Mar, Barcelona, Spain.

Tamara Biedermann Villagra (TB)

Physical Medicine and Rehabilitation Department, Fundació ASPACE Catalunya, Barcelona, Spain.

Joan Jiménez-Balado (J)

Neurovascular Research Lab, Hospital del Mar Research Institute, Barcelona, Spain.

Jordi Jiménez Redondo (JJ)

Technical Secretariat and Research Commission, Fundació ASPACE Catalunya, Barcelona, Spain.

Bernat Bertran Recasens (BB)

Neurology Department, Fundació ASPACE Catalunya, Barcelona, Spain; Neurology Department, Hospital del Mar, Barcelona, Spain. Electronic address: bbertran@aspace.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH